Literature DB >> 27591041

Protective altruistic phlebotomy: hereditary haemochromatosis presenting as hepatocellular carcinoma in a non-cirrhotic 83-year-old man.

Kohtaro Ooka1, Ifeyinwa Onyiuke2, Xuchen Zhang3, Tamar Hamosh Taddei4.   

Abstract

Hereditary haemochromatosis is a multisystem disorder of iron metabolism. Hepatic manifestations include hepatomegaly, cirrhosis and hepatocellular carcinoma. Hepatocellular carcinoma is almost always preceded by cirrhosis. We present a case of an 83-year-old man without history of liver disease or iron overload who presented with abdominal pain. Workup revealed mildly elevated transaminases, ferritin of 3996 and a solitary liver tumour. Biopsy was consistent with hepatocellular carcinoma in a background of haemosiderosis without cirrhosis. He was diagnosed with hereditary haemochromatosis and hepatocellular carcinoma. He underwent a partial hepatectomy and was started on routine phlebotomy and surveillance imaging. He has improved and has not had signs of recurrence or new complications of haemochromatosis. We suggest a possible reason for his unique and late presentation. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27591041      PMCID: PMC5020720          DOI: 10.1136/bcr-2016-216649

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.

Authors:  S von Delius; C Lersch; E Schulte-Frohlinde; F Fend; M Dobritz; R M Schmid; F Eckel
Journal:  Z Gastroenterol       Date:  2006-01       Impact factor: 2.000

Review 2.  Hepatocellular carcinoma in non-cirrhotic liver without evidence of iron overload in a patient with primary hemochromatosis. Review.

Authors:  Parminder Singh; Harneet Kaur; Robert G Lerner; Roshan Patel; Shamudheen M Rafiyath; Gurpreet Singh Lamba
Journal:  J Gastrointest Cancer       Date:  2012-03

3.  Hepatoma in a 40-year old male with hereditary hemochromatosis in the absence of cirrhosis. Implications of molecular diagnosis.

Authors:  A Brage; S Tomé; B Figueruela; I Abdulkader; J Martínez; E Varó
Journal:  Rev Esp Enferm Dig       Date:  2002-08       Impact factor: 2.086

Review 4.  [Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis].

Authors:  M Pellisé; J González-Abraldes; M Navasa; R Miquel; M Bruguera
Journal:  Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.102

Review 5.  Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.

Authors:  J Goh; G Callagy; G McEntee; J C O'Keane; A Bomford; J Crowe
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-08       Impact factor: 2.566

6.  Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis.

Authors:  Tadd Hiatt; James F Trotter; Igal Kam
Journal:  Am J Med Sci       Date:  2007-09       Impact factor: 2.378

Review 7.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

Review 8.  Hemochromatosis: an endocrine liver disease.

Authors:  Antonello Pietrangelo
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma.

Authors:  Teresa Pollicino; Alberto Vegetti; Carlo Saitta; Francesca Ferrara; Elena Corradini; Giuseppina Raffa; Antonello Pietrangelo; Giovanni Raimondo
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

10.  Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis.

Authors:  Melanie Beaton; Dominique Guyader; Yves Deugnier; Romain Moirand; Subrata Chakrabarti; Paul Adams
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.